Related Experiment Videos
Abstract:
Pseudomembranous colitis may arise as a severe complication of chemotherapy with antibiotics. Lincomycin and clindamycin are especially incriminated, but the condition has also been reported after treatment with other broad-spectrum antibiotics. The endoscopic findings are suggestive, though not specific. Overall mortality is estimated to be 10--20%. There is an increased risk in patients with a previous history and pseudomembranous colitis in relatives of these patients.
Insights
Pseudomembranous colitis is a severe complication of antibiotic chemotherapy, particularly with lincomycin and clindamycin. This condition, with a 10-20% mortality rate, is more likely in patients with a prior history or family history.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Pharmacology
Context:
- Antibiotic-associated diarrhea is a common adverse effect of antimicrobial therapy.
- Pseudomembranous colitis represents a severe spectrum of this condition.
- Certain antibiotics, notably lincomycin and clindamycin, are frequently implicated.
Purpose:
- To summarize the etiology, clinical presentation, and risk factors of pseudomembranous colitis.
- To highlight the diagnostic challenges and mortality associated with this condition.
- To inform healthcare providers about potential antibiotic-induced complications.
Summary:
- Pseudomembranous colitis is a serious complication linked to broad-spectrum antibiotic use, especially lincomycin and clindamycin.
- While endoscopic findings are suggestive, diagnosis requires clinical suspicion.
- Mortality ranges from 10% to 20%, with increased risk in patients with prior history or family history.
Impact:
- Enhances understanding of antibiotic-induced gastrointestinal complications.
- Emphasizes the importance of judicious antibiotic prescribing.
- Informs clinical management and risk assessment for pseudomembranous colitis.